Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03096548 · ClinicalTrials.gov registry record · NA
Sun Safety Ink! A Sun Safety Program for the Tattoo Community
A NA study, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 1,820
- Enrollment target
NCT03096548: Completed NA study, sponsored by Klein Buendel.
NCT03096548 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 1,820 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03096548, a NA study, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,820 participants
- Enrollment target
Study Summary
Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo studios because tattoo aftercare recommendations can include sun protection for tattoos, and studios offer an opportunity to reach younger adults who are significantly more likely to sunburn and less likely to practice sun safety. The study will assess the effectiveness of SSI! at (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.
Primary Outcome
Sun protection practices (sunscreen application/reapplication and Sun Protection Factor (SPF); use of lip balm, hats, protective clothing, sunglasses, shade) of tattooed and non-tattooed skin will be assessed in an online survey.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Sun Safety Ink! Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03096548 record still lists
NCT03096548 is an interventional study that assigns participants to a tested intervention. Its 1,820 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT03096548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03096548 about?
NCT03096548 is a clinical study titled "Sun Safety Ink! A Sun Safety Program for the Tattoo Community". Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo ...
What is the current status of trial NCT03096548?
This trial is currently completed. It is a NA study. The enrollment target is 1,820 participants. The study started on 2017-06-15. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03096548?
The interventions under investigation include: Attention Control (BEHAVIORAL), Sun Safety Ink! Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03096548?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03096548's enrollment target sits among peer trials
1,820 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI